REFERENCES
- Thuruthumaly C, Yee DC, Rao PK. Presumed ocular histoplasmosis. Curr Opin Ophthalmol. 2014;25:508–512.
- Diaz RI, Sigler EJ, Rafieetary MR, et al. Ocular histoplasmosis syndrome. Surv Ophthalmol. 2015;60:279–295.
- Smith RE, Ganley JP. An epidemiologic study of presumed ocular histoplasmosis. Trans Am Acad Ophthalmol Otolaryngol. 1971;75:994–1005.
- Nielsen JS, Fick TA, Saggau DD, et al. Intravitreal anti-vascular endothelial growth factor therapy for choroidal neovascularization secondary to ocular histoplasmosis syndrome. Retina. 2012;32:468–472.
- Adhi M, Duker JS. Optical coherence tomography–current and future applications. Curr Opin Ophthalmol. 2013;24:213–221.
- Zaharova E, Sherman J. The use of SD-OCT in the differential diagnosis of dots, spots and other white retinal lesions. Eye and Brain. 2011;3:69–80.
- Staurenghi G, Sadda S, Chakravarthy U, et al. Proposed lexicon for anatomic landmarks in normal posterior segment spectral-domain optical coherence tomography: the IN*OCT consensus. Ophthalmology. 2014;121:1572–1578.
- Ho J, Witkin AJ, Liu J, et al. Documentation of intraretinal retinal pigment epithelium migration via high-speed ultrahigh-resolution optical coherence tomography. Ophthalmology. 2011;118:687–693.
- Piri N, Nesmith BL, Schaal S. Choroidal hyperreflective foci in Stargardt disease shown by spectral-domain optical coherence tomography imaging: correlation with disease severity. JAMA Ophthalmol. 2015;133:398–405.
- Michalewska Z, Michalewski J, Nawrocka Z, et al. Suprachoroidal layer and suprachoroidal space delineating the outer margin of the choroid in swept-source optical coherence tomography. Retina. 2015;35:244–249.
- Yiu G, Pecen P, Sarin N, et al. Characterization of the choroid-scleral junction and suprachoroidal layer in healthy individuals on enhanced-depth imaging optical coherence tomography. JAMA Ophthalmol. 2014;132:174–181.
- Ramaiya KJ, Blinder KJ, Ciulla T, et al. Ranibizumab versus photodynamic therapy for presumed ocular histoplasmosis syndrome. Ophthalmic Surg Lasers Imaging Retina. 2013;44:17–21.
- Ehrlich R, Ciulla TA, Maturi R, et al. Intravitreal bevacizumab for choroidal neovascularization secondary to presumed ocular histoplasmosis syndrome. Retina. 2009;29:1418–1423.
- Kuroda M, Hirami Y, Hata M, et al. Intraretinal hyperreflective foci on spectral-domain optical coherence tomographic images of patients with retinitis pigmentosa. Clin Ophthalmol. 2014;8:435–440.
- De Benedetto U, Sacconi R, Pierro L, et al. Optical coherence tomographic hyperreflective foci in early stages of diabetic retinopathy. Retina. 2015;35:449–453.
- Framme C, Wolf S, Wolf-Schnurrbusch U. Small dense particles in the retina observable by spectral-domain optical coherence tomography in age-related macular degeneration. Invest Ophthalmol Vis Sci. 2010;51:5965–5969.
- Michalewski J, Nawrocki J, Trebinska M, et al. Spectral-domain optical coherence tomography features preceding new-onset neovascular membrane formation. Can J Ophthalmol. 2014;49:339–344.
- Lewis ML, Schiffman JC. Long-term follow-up of the second eye in ocular histoplasmosis. Int Ophthalmol Clin. 1983;23:125–135.
- Olk RJ, Burgess DB, McCormick PA. Subfoveal and juxtafoveal subretinal neovascularization in the presumed ocular histoplasmosis syndrome. Visual prognosis. Ophthalmology. 1984;91:1592–1602.
- Sawelson H, Goldberg RE, Annesley WH, Jr, et al. Presumed ocular histoplasmosis syndrome. The fellow eye. Arch Ophthalmol. 1976;94:221–224.
- Gutman FA. The natural course of active choroidal lesions in the presumed ocular histoplasmosis syndrome. Trans Am Ophthalmol Soc. 1979;77:515–541.